Faecal calprotectin is the biomarker that best distinguishes remission from different degrees of endoscopic activity in Crohn's disease.

Francisco Guilherme Cancela E PennaRodrigo Macedo RosaPedro Ferrari Sales da CunhaStella Cristina Silva de SouzaMaria de Lourdes de Abreu Ferrari

Published in: BMC gastroenterology (2020)

fCal provides greater diagnostic accuracy than the other activity markers for endoscopic activity of patients with CD, moderate correlation to SES-CD, and a capacity to discriminate patients in remission from those with mild or moderate to severe activity.

Keyphrases

end stage renal disease
ultrasound guided
disease activity
newly diagnosed
chronic kidney disease
rheumatoid arthritis
patient reported outcomes